EP
MYOK

Elkfork Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Elkfork Partners’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$38K Hold
728
– – ﹤0.01% 1001
2019
Q2 		$37K Hold
728
– – ﹤0.01% 1006
2019
Q1 		$38K Buy
728
+168
+30% +$7.74K ﹤0.01% 994
2018
Q4 		$27K Buy
+560
New +$30.8K ﹤0.01% 967

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Elkfork Partners's MYOK Position: Q3 2019 in Review

Elkfork Partners held its MyoKardia, Inc. Common Stock (MYOK) position steady in Q3 2019 at 728 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Elkfork Partners first reported a position in MYOK in Q4 2018 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • Elkfork Partners held 728 shares of MyoKardia, Inc. Common Stock worth $38K as of Q3 2019.
  • Elkfork Partners left its MyoKardia, Inc. Common Stock share count unchanged in Q3 2019.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1001 holding.
  • Elkfork Partners first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.